These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9748483)

  • 1. A comparison of delta 9-THC and anandamide induced c-fos expression in the rat forebrain.
    McGregor IS; Arnold JC; Weber MF; Topple AN; Hunt GE
    Brain Res; 1998 Aug; 802(1-2):19-26. PubMed ID: 9748483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in naloxone modulation of Delta(9)-THC induced Fos expression in rat brain.
    Allen KV; McGregor IS; Hunt GE; Singh ME; Mallet PE
    Neuropharmacology; 2003 Feb; 44(2):264-74. PubMed ID: 12623225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.
    Romero J; García L; Cebeira M; Zadrozny D; Fernández-Ruiz JJ; Ramos JA
    Life Sci; 1995; 56(23-24):2033-40. PubMed ID: 7776829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
    Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of chronic nicotine exposure on Δ
    Miladinovic T; Manwell LA; Raaphorst E; Malecki SL; Rana SA; Mallet PE
    Pharmacol Biochem Behav; 2020 Jul; 194():172931. PubMed ID: 32353393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.
    Welch SP
    Drug Alcohol Depend; 1997 Apr; 45(1-2):39-45. PubMed ID: 9179505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strain.
    Arnold JC; Topple AN; Mallet PE; Hunt GE; McGregor IS
    Brain Res; 2001 Dec; 921(1-2):240-55. PubMed ID: 11720732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol-Mediated Induction of ΔFosB in the Mouse Forebrain.
    Lazenka MF; Tomarchio AJ; Lichtman AH; Greengard P; Flajolet M; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2015 Sep; 354(3):316-27. PubMed ID: 26099530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure.
    Burkey RT; Nation JR
    Exp Clin Psychopharmacol; 1997 Aug; 5(3):195-202. PubMed ID: 9260067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats.
    Wiley JL; LaVecchia KL; Karp NE; Kulasegram S; Mahadevan A; Razdan RK; Martin BR
    Exp Clin Psychopharmacol; 2004 Aug; 12(3):173-9. PubMed ID: 15301634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice.
    Fride E; Mechoulam R
    Brain Res Dev Brain Res; 1996 Aug; 95(1):131-4. PubMed ID: 8873985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated exposure to Delta(9)-tetrahydrocannabinol alters heroin-induced locomotor sensitisation and Fos-immunoreactivity.
    Singh ME; McGregor IS; Mallet PE
    Neuropharmacology; 2005 Dec; 49(8):1189-200. PubMed ID: 16137723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular effects of delta 9-tetrahydrocannabinol (THC), anandamide and N-arachidonoyldopamine (NADA) in the rat isolated aorta.
    O'Sullivan SE; Kendall DA; Randall MD
    Eur J Pharmacol; 2005 Jan; 507(1-3):211-21. PubMed ID: 15659311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide.
    Houser SJ; Eads M; Embrey JP; Welch SP
    Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of dopamine D1 receptors in delta 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain.
    Miyamoto A; Yamamoto T; Ohno M; Watanabe S; Tanaka H; Morimoto S; Shoyama Y
    Brain Res; 1996 Feb; 710(1-2):234-40. PubMed ID: 8963664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of subthalamic neuron activity by endocannabinoids.
    Morera-Herreras T; Ruiz-Ortega JA; Taupignon A; Baufreton J; Manuel I; Rodriguez-Puertas R; Ugedo L
    Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
    Welch SP; Dunlow LD; Patrick GS; Razdan RK
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.